Once coagulants have done their work, the next stage often involves disinfection, crucial for eliminating harmful pathogens that may cause waterborne diseases. Chlorine is one of the most commonly used disinfectants, effective against viruses, bacteria, and some protozoa. It can be added in the form of gas or liquid, and its residual effect continues to provide protection even after treatment. Alternative disinfectants include ozone and ultraviolet (UV) radiation. Ozone is a strong oxidizing agent that not only kills pathogens but also helps remove color and odors from water. UV radiation, on the other hand, is a chemical-free method that inactivates microorganisms by damaging their DNA.
Moreover, in the context of personalized medicine and novel drug formulations, the ability to customize intermediates allows researchers to tailor APIs to specific patient needs. This flexibility enhances the efficacy of treatments and could lead to better therapeutic outcomes.
The pharmaceutical intermediate market is influenced by a variety of factors, including technological advancements, regulatory developments, and evolving market needs. The rise in chronic diseases, an aging population, and the increasing demand for innovative therapies are driving the growth of this market. Additionally, the shift towards personalized medicine is creating a need for more sophisticated intermediates that can facilitate the development of tailored therapies.